easl studio s7e7- alcohol, cardiometabolic risks factors & sld – stigma to breakthrough therapies
Published 10 days ago • 115 plays • Length 36:46Download video MP4
Download video MP3
Similar videos
-
1:13
easl studio - s7e7 - alcohol, cardiometabolic risks factors & sld
-
34:11
easl studio s5 special episode - highlights from the easl sld summit 2023
-
0:43
easl studio s7e08 - promo video
-
34:48
easl studio s6e8 - is there a role for measuring blood ammonia in patients with cirrhosis?
-
37:13
easl studio s5e14 - hepatic encephalopathy: underdiagnosed and underestimated
-
31:04
easl studio s5e12 - psc and aih overlap syndrome: does it actually exist?
-
1:27
easl studio s7e9 - promo video - tips: how far can we go?
-
7:39
easl studio policy dialogues - episode 2 - the liver, alcohol, and politics
-
3:23
easl livertree video
-
44:23
easl studio midday talks: steatotic liver disease global consensus to change nomenclature
-
8:29
easl studio policy dialogues episode 3 - liver cancer: the risk of ignorance
-
1:11
easl studio s7e01 promo - are we relearning how to manage renal dysfunction in cirrhosis?
-
46:54
easl studio - season 1, episode 3 - the easl-lancet liver commission
-
45:47
easl studio s4e3 - a 360 approach to beat alcohol-related liver disease
-
0:16
easl studio promo
-
4:33
high cholesterol and familial hypercholesterolemia, animation
-
38:42
easl studio s5e9 - alcohol and the new nomenclature – a game-changer?
-
38:59
easl studio s07e01 - are we relearning how to manage renal dysfunction in cirrhosis?
-
1:05
easl studio - promo video - special edition – highlights from the easl sld summit 2023
-
41:46
easl studio s4e16 - highlights from the easl liver cancer summit 2023